4.8 Article

Optically Active CdSe-Dot/CdS-Rod Nanocrystals with Induced Chirality and Circularly Polarized Luminescence

期刊

ACS NANO
卷 12, 期 6, 页码 5341-5350

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.8b00112

关键词

CdSe-dot/CdS-rod; ligand-induced chirality; circular dichorism; circularly polarized luminescence; excitonic interactions; orbital coupling theory

资金

  1. National Natural Science Foundation of China [11404219, 61674074, 51402148]
  2. Shenzhen Innovation Project [JCYJ2015032414171163, JCYJ20170302142433007, JCYJ20160301113356947, KC2014JSQN0011A, JCYJ20160301113537474]
  3. Guangdong Distinguished Young Scholar of Natural Science Foundation [2017B030306010]
  4. Tianjin New Materials Science and Technology Major Project [16ZXCLGX00040]

向作者/读者索取更多资源

Ligand-induced chirality in semiconductor nanocrystals (NCs) has attracted attention because of the tunable optical properties of the NCs. Induced circular dichroism (CD) has been observed in CdX (X = S, Se, Te) NCs and their hybrids, but circularly polarized luminescence (CPL) in these fluorescent nanomaterials has been seldom reported. Herein, we describe the successful preparation of L- and D-cysteine-capped CdSe-dot/CdS-rods (DRs) with tunable CD and CPL behaviors and a maximum anisotropic factor (g(lum)) of 4.66 X 10(-4). The observed CD and CPL activities are sensitive to the relative absorption ratio of the CdS shell to the CdSe core, suggesting that the anisotropic g-factors in both CD and CPL increase to some extent for a smaller shell-to-core absorption ratio. In addition, the molar ratio of chiral cysteine to the DRs is investigated. Instead of enhancing the chiral interactions between the chiral molecules and DRs, an excess of cysteine molecules in aqueous solution inhibits both the CD and CPL activities. Such chiral and emissive NCs provide an ideal platform for the rational design of semiconductor nanomaterials with chiroptical properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据